Manager M&A

At Evotec's headquarters in Hamburg, Germany, the M & A Team is seeking a highly motivated and dedicated

Manager M&A & Valuation (all genders)

Full-time and permanent

Manager M&A & Valuation is a key contributor within Evotec's dedicated M&A team, supporting the execution of strategic transactions and valuation activities across the group. This role combines strong analytical capabilities with hands-on project management to drive high-impact M&A initiatives, including buy-side and sell-side deals, group valuation processes, and strategic financial assessments. Working closely with internal stakeholders and external advisors, the Manager will play a central role in shaping investment decisions and supporting the company's growth strategy.

Key Responsibilites:

M&A Process

• Cross functional project management of buy-side and sell-side transactions across the full deal lifecycle – reporting to the Head of M&A
• Own and maintain the financial and valuation models used for deal evaluation, investment/divestment cases, and scenario analysis
• Coordinate due diligence activities with internal workstream owners and manage VDR setup
• Assist in preparing materials for Management Board and Supervisory Board decision-making
• Liaise with external advisors (investment banks, legal counsel) to support contracting and negotiation processes
• Provide support in integration and separation planning in collaboration with functional teams

Group Valuation

• Maintain and enhance valuation models used for strategic planning and investment decision-making
• Support quarterly derivation of Group WACC in close alignment with the Treasury team
• Assist in scenario analysis and valuation assessments for strategic initiatives and partnerships
• Collaborate with FP&A and Controlling teams to ensure consistency and plausibility of valuation inputs

Financial Reporting Valuation

• Support Group Accounting with valuation models for IFRS goodwill impairment tests and German GAAP investment valuations
• Coordinate with external advisors on purchase price allocations (PPAs)
• Ensure alignment of valuation models with the Group's 5-year financial plan
• Assist in preparing valuation-related materials for financial audits and external reporting
• Engage in discussions with auditors on any financial reporting valuation performed

Qualifications:

• Minimum Bachelor's degree in Finance, Economics, or a related field
• Experience with M&A processes, ideally gained through experience in transaction consulting, investment banking, or corporate M&A
• Solid background in financial modelling and valuation CVA or CFA qualification preferred
• Excellent analytical and organizational skills
• Strong communication skills and ability to work effectively with cross-functional teams and external partners
• Experience in the biopharma industry or with valuation of pharmaceutical assets is a plus
• Strategic mindset with hands-on execution capability
• Proficiency in Excel and Powerpoint as well as ideally Power BI, Power Pivot and Power Query
• Proficiency in oral and written English

Our offer:

• A position within a vigorous and exciting professional environment promoted by an open culture and a spirit of community
• A diverse, international workforce with a dynamic working environment that fosters creativity, innovations and teamwork
• 30 days of annual holiday, monthly allowance for public transportation, and in-house canteen
• Capital forming benefits, flexible working hours, holiday pay, and annual bonus depending on performance

To apply, please click on the "Apply" button and provide your application documents (CV and cover letter, including earliest possible start date and salary requirements). We are looking forward to getting to know you and to your application.

FR : Dans le cadre de sa politique Diversité, Evotec étudie, à compétences égales, toutes les candidatures dont celles des personnes en situation de handicap.

ENG : In the frame of our Diversity policy, Evotec considers, with equal competences, all applications including people with disabilities.